検索結果
-
Perry Nisen - Chief Executive Officer and Director - has a PhD in Medicine from Albert Einstein College of Medicine of Yeshiva University and Bachelor of Science in Medical Microbiology from Stanford University.Quanta Therapeutics - バイオテクノロジー - アメリカ合衆国（米国）
-
Noreen Henig - Director - has a MD Distinction in Immunology from Albert Einstein College of Medicine of Yeshiva University and BA History of Art from Yale University.Avidity Biosciences - バイオテクノロジー - アメリカ合衆国（米国）
-
Perry Nisen - Executive Partner, Private Equity - has a PhD in Medicine from Albert Einstein College of Medicine of Yeshiva University and Bachelor of Science in Medical Microbiology from Stanford University.Sofinnova Investments - ファンド - アメリカ合衆国（米国）
-
Mollie Ranalletta - Vice President, Head of Project Management, Deerfield Discovery and Development - has a Doctor of Philosophy in Biochemistry from Albert Einstein College of Medicine of Yeshiva University and Master of Science in Animal Science from Purdue University.Deerfield - ファンド - アメリカ合衆国（米国）
-
Theodore Feldman - Chief Medical Officer - は、Albert Einstein College of Medicine of Yeshiva UniversityのDoctor of Medicineを保持。Rightway Healthcare - バイオテクノロジー - アメリカ合衆国（米国）
-
Jeffrey Silber - Chief Medical Officer - has a Doctor of Medicine from Albert Einstein College of Medicine of Yeshiva University and Bachelor of Science in Biology from Harvard University.Vedanta Biosciences - バイオテクノロジー - アメリカ合衆国（米国）
